Sesen Bio Inc (NASDAQ:SESN)
| 0.5134 Delayed Data As of 4:01pm ET |  +0.0652 / +14.55%Today’s Change | 0.37 Today|||52-Week Range 6.04 | -37.01% Year-to-Date |
Latest SESN News | Press Releases
| AbbVie (ABBV) Buys Option Rights to NextGen Inflammation Drug May 17 / Zacks.com - Paid Partner Content | Will Repligen's (RGEN) COVID Woes Be Offset by Product Demand? May 16 / Zacks.com - Paid Partner Content |
| Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates May 17 / Zacks.com - Paid Partner Content | Lilly's (LLY) Diabetes Treatment Tirzepatide Gets FDA Nod May 16 / Zacks.com - Paid Partner Content |
| CRISPR (CRSP) Focuses on Pipeline Amid Lack of Marketed Drugs May 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.45 |
| Today’s open | 0.43 |
| Day’s range | 0.49 - 0.54 |
| Volume | 152,786 |
| Average volume (3 months) | 3,194,470 |
| Market cap | $93.0M |
Data as of 4:01pm ET, 05/18/2022
Growth & Valuation
| Earnings growth (last year) | +99.06% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +136.24% |
| P/E ratio | 1.5 |
| Price/Sales | 5.60 |
| Price/Book | 0.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LIFEaTyr Pharma Inc | -0.24 | -7.50% |
| PBYIPuma Biotechnology I... | -0.05 | -2.50% |
| PTNPalatin Technologies... | -0.03 | -7.18% |
| TRVITrevi Therapeutics I... | +0.01 | +0.45% |
Data as of 4:01pm ET, 05/18/2022
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $26.5M |
| Annual profit (last year) | -$336.0K |
| Net profit margin | -1.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
